Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors.
<h4>Background</h4>There is an urgent need to better understand the diverse presentations, risk factors, and outcomes of immune checkpoint inhibitor (ICI)-associated cardiovascular toxicity. There remains a lack of consensus surrounding cardiovascular screening, risk stratification, and...
Saved in:
| Main Authors: | Jennifer M Kwan, Miles Shen, Narjes Akhlaghi, Jiun-Ruey Hu, Ruben Mora, James L Cross, Matthew Jiang, Michael Mankbadi, Peter Wang, Saif Zaman, Seohyuk Lee, Yunju Im, Attila Feher, Yi-Hwa Liu, Shuangge S Ma, Weiwei Tao, Wei Wei, Lauren A Baldassarre |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0314555 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Night Sweats as a Prominent Symptom of a Patient Presenting with Pulmonary Embolism
by: Attila Feher, et al.
Published: (2015-01-01) -
Removed: “Kiosk 8Q-FA-03—Gedatolisib Associated Acute Myocarditis in a Patient with Breast Adenocarcinoma” [Journal of Cardiovascular Magnetic Resonance 26 (2024) 100856]
by: Mohamad Khattab, et al.
Published: (2024-01-01) -
A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01) -
How Do Arabidopsis Seedlings Sense and React to Increasing Ambient Temperatures?
by: Attila Fehér, et al.
Published: (2025-01-01) -
Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)